Diabetes
Metabolic·MeSH: Diabetes Mellitus
Prevalence
10700.0 / 100K
Incidence
600.0 / 100K/yr
264 drugs in development·84 companies·30 clinical trials
Drug Pipeline by Phase
Approved(38)
Phase 3(53)
Phase 2(43)
Phase 1(44)
Preclinical(31)
Unknown(9)
BLA Filed(1)
| Drug | Company |
|---|---|
| teplizumab | PROVENTION BIO, INC. (PBI) |
Early Phase 1(2)
N/A(4)
Phase 1/Phase 2(7)
Phase 2/Phase 3(5)
Phase 4(27)
Compare drugs
Frequently asked questions
How many drugs are in development for Diabetes?
BioSniper tracks 264 drugs in development for Diabetes across 84 companies.
How many clinical trials target Diabetes?
There are 30 clinical trials targeting Diabetes tracked by BioSniper.
What is the prevalence of Diabetes?
The estimated prevalence of Diabetes is approximately 10700.0 per 100,000 population.
Deep-dive into Diabetes
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis